{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T01:27:53Z","timestamp":1794014873092,"version":"4.8.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T00:00:00Z","timestamp":1766361600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T00:00:00Z","timestamp":1766966400000},"content-version":"vor","delay-in-days":7,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32161160323"],"award-info":[{"award-number":["32161160323"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Glioblastoma (GBM), a highly aggressive form of glioma, poses serious harm to patients due to its extremely poor prognosis and severe resistance to chemotherapeutic agents. Although programmed necrosis (necroptosis) has been implicated in GBM progression, its precise function and biological significance in GBM remain incompletely defined. Here, we show that elevated expression of key necroptotic machinery proteins, including RIPK1 and MLKL, is positively associated with disease progression and predicts poor prognosis in glioma patients. Functionally, RIPK1 promotes glioblastoma cell proliferation, migration, and invasion. Genetic ablation of RIPK1 induces cell-cycle arrest and suppresses tumor growth in subcutaneous xenograft models, whereas pharmacological inhibition of RIPK1 with necrostatin-1 fails to restrict GBM cell expansion, suggesting that RIPK1 exerts oncogenic effects independent of its canonical necroptotic role. Notably, dual apoptosis- and necroptosis-inducing agents, ZZW115 and citronellol, synergize with temozolomide (TMZ)\u2014the first-line chemotherapy for GBM\u2014to enhance glioma cell death and increase tumor clearance in an orthotopic mouse glioma model. Collectively, these findings identify RIPK1 as a critical driver of glioma malignancy and underscore the therapeutic potential of activating necroptosis to augment TMZ efficacy, providing a framework for novel prognostic and treatment strategies in glioma.<\/jats:p>","DOI":"10.1038\/s41419-025-08377-3","type":"journal-article","created":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T20:35:46Z","timestamp":1766435746000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Necroptotic signaling orchestrates glioblastoma malignancy and potentiates temozolomide response"],"prefix":"10.1038","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6033-0285","authenticated-orcid":false,"given":"Yuanyuan","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxin","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenqing","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Geng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zerui","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiasong","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianglong","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danfeng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adi","family":"Idris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijun","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0794-4122","authenticated-orcid":false,"given":"Zhipeng","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3463-3175","authenticated-orcid":false,"given":"Jixi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,22]]},"reference":[{"key":"8377_CR1","doi-asserted-by":"publisher","first-page":"iv1","DOI":"10.1093\/neuonc\/noaa200","volume":"22","author":"QT Ostrom","year":"2020","unstructured":"Ostrom QT, Patil N, Cioffi G, Waite K, Kruchko C, Barnholtz-Sloan JS. CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2013-2017. Neuro Oncol. 2020;22:iv1\u2013iv96.","journal-title":"Neuro Oncol"},{"key":"8377_CR2","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1007\/s00401-016-1545-1","volume":"131","author":"DN Louis","year":"2016","unstructured":"Louis DN, Perry A, Reifenberger G, von Deimling A, Figarella-Branger D, Cavenee WK, et al. The 2016 World Health Organization classification of tumors of the central nervous system: a summary. Acta Neuropathol. 2016;131:803\u201320.","journal-title":"Acta Neuropathol"},{"key":"8377_CR3","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1111\/nan.12432","volume":"44","author":"P Wesseling","year":"2018","unstructured":"Wesseling P, Capper D. WHO 2016 Classification of gliomas. Neuropathol Appl Neurobiol. 2018;44:139\u201350.","journal-title":"Neuropathol Appl Neurobiol"},{"key":"8377_CR4","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1038\/s41571-018-0003-5","volume":"15","author":"M Lim","year":"2018","unstructured":"Lim M, Xia Y, Bettegowda C, Weller M. Current state of immunotherapy for glioblastoma. Nat Rev Clin Oncol. 2018;15:422\u201342.","journal-title":"Nat Rev Clin Oncol"},{"key":"8377_CR5","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.3389\/fonc.2020.01097","volume":"10","author":"Y An","year":"2020","unstructured":"An Y, Wang Q, Zhang L, Sun F, Zhang G, Dong H, et al. OSlgg: an online prognostic biomarker analysis tool for low-grade glioma. Front Oncol. 2020;10:1097.","journal-title":"Front Oncol"},{"key":"8377_CR6","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1093\/neuonc\/noab106","volume":"23","author":"DN Louis","year":"2021","unstructured":"Louis DN, Perry A, Wesseling P, Brat DJ, Cree IA, Figarella-Branger D, et al. The 2021 WHO Classification of tumors of the central nervous system: a summary. Neuro Oncol. 2021;23:1231\u201351.","journal-title":"Neuro Oncol"},{"key":"8377_CR7","first-page":"17","volume":"4","author":"N Singh","year":"2021","unstructured":"Singh N, Miner A, Hennis L, Mittal S. Mechanisms of temozolomide resistance in glioblastoma\u2014a comprehensive review. Cancer Drug Resist. 2021;4:17\u201343.","journal-title":"Cancer Drug Resist"},{"key":"8377_CR8","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.682415","volume":"12","author":"WJ Zhao","year":"2021","unstructured":"Zhao WJ, Ou GY, Lin WW. Integrative analysis of neuregulin family members-related tumor microenvironment for predicting the prognosis in gliomas. Front Immunol. 2021;12:682415.","journal-title":"Front Immunol"},{"key":"8377_CR9","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1093\/neuonc\/noaa106","volume":"22","author":"PY Wen","year":"2020","unstructured":"Wen PY, Weller M, Lee EQ, Alexander BM, Barnholtz-Sloan JS, Barthel FP, et al. Glioblastoma in adults: a Society For Neuro-Oncology (SNO) and European Society of Neuro-Oncology (EANO) consensus review on current management and future directions. Neuro Oncol. 2020;22:1073\u2013113.","journal-title":"Neuro Oncol"},{"key":"8377_CR10","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1056\/NEJMra0708126","volume":"359","author":"PY Wen","year":"2008","unstructured":"Wen PY, Kesari S. Malignant gliomas in adults. N Engl J Med. 2008;359:492\u2013507.","journal-title":"N Engl J Med"},{"key":"8377_CR11","doi-asserted-by":"publisher","first-page":"1795","DOI":"10.3390\/cancers13081795","volume":"13","author":"E Cruz Da Silva","year":"2021","unstructured":"Cruz Da Silva E, Mercier MC, Etienne-Selloum N, Dontenwill M, Choulier LA. A Systematic review of glioblastoma-targeted therapies in phases II, III, and IV Clinical Trials. Cancers. 2021;13:1795","journal-title":"Cancers"},{"key":"8377_CR12","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1097\/00006123-200207000-00002","volume":"51","author":"SM Raza","year":"2002","unstructured":"Raza SM, Lang FF, Aggarwal BB, Fuller GN, Wildrick DM, Sawaya R. Necrosis and glioblastoma: a friend or a foe? A review and a hypothesis. Neurosurgery. 2002;51:2\u201312.","journal-title":"Neurosurgery"},{"key":"8377_CR13","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1038\/s41580-020-0270-8","volume":"21","author":"S Bedoui","year":"2020","unstructured":"Bedoui S, Herold MJ, Strasser A. Emerging connectivity of programmed cell death pathways and its physiological implications. Nat Rev Mol Cell Biol. 2020;21:678\u201395.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"8377_CR14","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-024-06559-z","volume":"15","author":"MK Preedy","year":"2024","unstructured":"Preedy MK, White MRH, Tergaonkar V. Cellular heterogeneity in TNF\/TNFR1 signalling: live cell imaging of cell fate decisions in single cells. Cell Death Dis. 2024;15:202.","journal-title":"Cell Death Dis"},{"key":"8377_CR15","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1038\/s12276-025-01470-9","volume":"57","author":"SH Dho","year":"2025","unstructured":"Dho SH, Cho M, Woo W, Jeong S, Kim LK. Caspases as master regulators of programmed cell death: apoptosis, pyroptosis and beyond. Exp Mol Med. 2025;57:1121\u201332.","journal-title":"Exp Mol Med"},{"key":"8377_CR16","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1016\/j.cell.2009.05.021","volume":"137","author":"S He","year":"2009","unstructured":"He S, Wang L, Miao L, Wang T, Du F, Zhao L, et al. Receptor-interacting protein kinase-3 determines cellular necrotic response to TNF-alpha. Cell. 2009;137:1100\u201311.","journal-title":"Cell"},{"key":"8377_CR17","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1007\/s10495-014-1061-5","volume":"20","author":"J Huang","year":"2015","unstructured":"Huang J, Yu S, Ji C, Li J. Structural basis of cell apoptosis and necrosis in TNFR signaling. Apoptosis. 2015;20:210\u20135.","journal-title":"Apoptosis"},{"key":"8377_CR18","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1016\/j.cell.2009.05.037","volume":"137","author":"YS Cho","year":"2009","unstructured":"Cho YS, Challa S, Moquin D, Genga R, Ray TD, Guildford M, et al. Phosphorylation-driven assembly of the RIP1-RIP3 complex regulates programmed necrosis and virus-induced inflammation. Cell. 2009;137:1112\u201323.","journal-title":"Cell"},{"key":"8377_CR19","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/j.cell.2012.06.019","volume":"150","author":"J Li","year":"2012","unstructured":"Li J, McQuade T, Siemer AB, Napetschnig J, Moriwaki K, Hsiao YS, et al. The RIP1\/RIP3 necrosome forms a functional amyloid signaling complex required for programmed necrosis. Cell. 2012;150:339\u201350.","journal-title":"Cell"},{"key":"8377_CR20","doi-asserted-by":"publisher","first-page":"2888","DOI":"10.1038\/s41418-021-00790-3","volume":"28","author":"P Mei","year":"2021","unstructured":"Mei P, Xie F, Pan J, Wang S, Gao W, Ge R, et al. E3 ligase TRIM25 ubiquitinates RIP3 to inhibit TNF-induced cell necrosis. Cell Death Differ. 2021;28:2888\u201399.","journal-title":"Cell Death Differ"},{"key":"8377_CR21","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1038\/s41418-020-00722-7","volume":"28","author":"Y Meng","year":"2021","unstructured":"Meng Y, Sandow JJ, Czabotar PE, Murphy JM. The regulation of necroptosis by post-translational modifications. Cell Death Differ. 2021;28:861\u201383.","journal-title":"Cell Death Differ"},{"key":"8377_CR22","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1038\/cr.2013.171","volume":"24","author":"X Chen","year":"2014","unstructured":"Chen X, Li W, Ren J, Huang D, He WT, Song Y, et al. Translocation of mixed lineage kinase domain-like protein to plasma membrane leads to necrotic cell death. Cell Res. 2014;24:105\u201321.","journal-title":"Cell Res"},{"key":"8377_CR23","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.cell.2011.11.031","volume":"148","author":"L Sun","year":"2012","unstructured":"Sun L, Wang H, Wang Z, He S, Chen S, Liao D, et al. Mixed lineage kinase domain-like protein mediates necrosis signaling downstream of RIP3 kinase. Cell. 2012;148:213\u201327.","journal-title":"Cell"},{"key":"8377_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2021.105784","volume":"172","author":"AA Farooqi","year":"2021","unstructured":"Farooqi AA, Naureen H, Zahid R, Youssef L, Attar R, Xu B. Cancer chemopreventive role of fisetin: regulation of cell signaling pathways in different cancers. Pharmacol Res. 2021;172:105784.","journal-title":"Pharmacol Res"},{"key":"8377_CR25","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/j.molcel.2019.09.006","volume":"76","author":"AJ Legrand","year":"2019","unstructured":"Legrand AJ, Konstantinou M, Goode EF, Meier P. The Diversification of cell death and immunity: memento mori. Mol Cell. 2019;76:232\u201342.","journal-title":"Mol Cell"},{"key":"8377_CR26","doi-asserted-by":"publisher","first-page":"9714","DOI":"10.1073\/pnas.1901179116","volume":"116","author":"A Degterev","year":"2019","unstructured":"Degterev A, Ofengeim D, Yuan J. Targeting RIPK1 for the treatment of human diseases. Proc Natl Acad Sci USA. 2019;116:9714\u201322.","journal-title":"Proc Natl Acad Sci USA"},{"key":"8377_CR27","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-51332-7","volume":"15","author":"SM Batool","year":"2024","unstructured":"Batool SM, Escobedo AK, Hsia T, Ekanayake E, Khanna SK, Gamblin AS, et al. Clinical utility of a blood-based assay for the detection of IDH1.R132H-mutant gliomas. Nat Commun. 2024;15:7074.","journal-title":"Nat Commun"},{"key":"8377_CR28","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/S1470-2045(09)70262-1","volume":"11","author":"R Yerushalmi","year":"2010","unstructured":"Yerushalmi R, Woods R, Ravdin PM, Hayes MM, Gelmon KA. Ki67 in breast cancer: prognostic and predictive potential. Lancet Oncol. 2010;11:174\u201383.","journal-title":"Lancet Oncol"},{"key":"8377_CR29","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1038\/s41574-021-00550-w","volume":"17","author":"G Raverot","year":"2021","unstructured":"Raverot G, Ilie MD, Lasolle H, Amodru V, Trouillas J, Castinetti F, et al. Aggressive pituitary tumours and pituitary carcinomas. Nat Rev Endocrinol. 2021;17:671\u201384.","journal-title":"Nat Rev Endocrinol"},{"key":"8377_CR30","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1038\/nrc1802","volume":"6","author":"ML Whitfield","year":"2006","unstructured":"Whitfield ML, George LK, Grant GD, Perou CM. Common markers of proliferation. Nat Rev Cancer. 2006;6:99\u2013106.","journal-title":"Nat Rev Cancer"},{"key":"8377_CR31","doi-asserted-by":"publisher","first-page":"4244","DOI":"10.1111\/cas.15567","volume":"113","author":"B Ma","year":"2022","unstructured":"Ma B, Ueda H, Okamoto K, Bando M, Fujimoto S, Okada Y, et al. TIMP1 promotes cell proliferation and invasion capability of right-sided colon cancers via the FAK\/Akt signaling pathway. Cancer Sci. 2022;113:4244\u201357.","journal-title":"Cancer Sci"},{"key":"8377_CR32","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.3390\/cells8101118","volume":"8","author":"CY Loh","year":"2019","unstructured":"Loh CY, Chai JY, Tang TF, Wong WF, Sethi G, Shanmugam MK. et al. The E-cadherin and N-cadherin switch in epithelial-to-mesenchymal transition: signaling, therapeutic implications, and challenges. Cells. 2019;8:1118","journal-title":"Cells"},{"key":"8377_CR33","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1126\/science.aaf7463","volume":"353","author":"A Kanakkanthara","year":"2016","unstructured":"Kanakkanthara A, Jeganathan KB, Limzerwala JF, Baker DJ, Hamada M, Nam HJ, et al. Cyclin A2 is an RNA-binding protein that controls Mre11 mRNA translation. Science. 2016;353:1549\u201352.","journal-title":"Science"},{"key":"8377_CR34","doi-asserted-by":"publisher","first-page":"e123","DOI":"10.1371\/journal.pbio.0050123","volume":"5","author":"A Lindqvist","year":"2007","unstructured":"Lindqvist A, van Zon W, Karlsson Rosenthal C, Wolthuis RM. Cyclin B1-Cdk1 activation continues after centrosome separation to control mitotic progression. PLoS Biol. 2007;5:e123.","journal-title":"PLoS Biol"},{"key":"8377_CR35","doi-asserted-by":"publisher","DOI":"10.1038\/s41698-024-00787-4","volume":"9","author":"D Kim","year":"2025","unstructured":"Kim D, Chung H, Liu W, Jeong K, Ozmen TY, Ozmen F, et al. Cyclin E1\/CDK2 activation defines a key vulnerability to WEE1 kinase inhibition in gynecological cancers. NPJ Precis Oncol. 2025;9:3.","journal-title":"NPJ Precis Oncol"},{"key":"8377_CR36","doi-asserted-by":"publisher","first-page":"10556","DOI":"10.1073\/pnas.1811100115","volume":"115","author":"Z Horn","year":"2018","unstructured":"Horn Z, Behesti H, Hatten ME. N-cadherin provides a cis and trans ligand for astrotactin that functions in glial-guided neuronal migration. Proc Natl Acad Sci USA. 2018;115:10556\u201363.","journal-title":"Proc Natl Acad Sci USA"},{"key":"8377_CR37","doi-asserted-by":"publisher","first-page":"1328","DOI":"10.3390\/biomedicines9101328","volume":"9","author":"C Noronha","year":"2021","unstructured":"Noronha C, Ribeiro AS, Taipa R, Castro DS, Reis J, Faria C. et al. Cadherin Expression and EMT: a focus on gliomas. Biomedicines. 2021;9:1328","journal-title":"Biomedicines"},{"key":"8377_CR38","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-26423-4","volume":"12","author":"X Mei","year":"2021","unstructured":"Mei X, Guo Y, Xie Z, Zhong Y, Wu X, Xu D, et al. RIPK1 regulates starvation resistance by modulating aspartate catabolism. Nat Commun. 2021;12:6144.","journal-title":"Nat Commun"},{"key":"8377_CR39","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.gendis.2016.04.007","volume":"3","author":"SY Lee","year":"2016","unstructured":"Lee SY. Temozolomide resistance in glioblastoma multiforme. Genes Dis. 2016;3:198\u2013210.","journal-title":"Genes Dis"},{"key":"8377_CR40","doi-asserted-by":"publisher","first-page":"2046","DOI":"10.1038\/s41418-019-0298-5","volume":"26","author":"T Frank","year":"2019","unstructured":"Frank T, Tuppi M, Hugle M, Dotsch V, van Wijk SJL, Fulda S. Cell cycle arrest in mitosis promotes interferon-induced necroptosis. Cell Death Differ. 2019;26:2046\u201360.","journal-title":"Cell Death Differ"},{"key":"8377_CR41","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1038\/cdd.2016.102","volume":"24","author":"K Rohde","year":"2017","unstructured":"Rohde K, Kleinesudeik L, Roesler S, Lowe O, Heidler J, Schroder K, et al. A Bak-dependent mitochondrial amplification step contributes to Smac mimetic\/glucocorticoid-induced necroptosis. Cell Death Differ. 2017;24:83\u201397.","journal-title":"Cell Death Differ"},{"key":"8377_CR42","doi-asserted-by":"publisher","first-page":"2500","DOI":"10.1172\/JCI127223","volume":"129","author":"P Santofimia-Castano","year":"2019","unstructured":"Santofimia-Castano P, Xia Y, Lan W, Zhou Z, Huang C, Peng L, et al. Ligand-based design identifies a potent NUPR1 inhibitor exerting anticancer activity via necroptosis. J Clin Investig. 2019;129:2500\u201313.","journal-title":"J Clin Investig"},{"key":"8377_CR43","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.21873\/invivo.11590","volume":"33","author":"WN Yu","year":"2019","unstructured":"Yu WN, Lai YJ, Ma JW, Ho CT, Hung SW, Chen YH, et al. Citronellol induces necroptosis of human lung cancer cells via the TNF-alpha pathway and reactive oxygen species accumulation. Vivo. 2019;33:1193\u2013201.","journal-title":"Vivo"},{"key":"8377_CR44","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1093\/neuonc\/nou087","volume":"16","author":"QT Ostrom","year":"2014","unstructured":"Ostrom QT, Bauchet L, Davis FG, Deltour I, Fisher JL, Langer CE, et al. The epidemiology of glioma in adults: a \u201cstate of the science\u201d review. Neuro Oncol. 2014;16:896\u2013913.","journal-title":"Neuro Oncol"},{"key":"8377_CR45","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1038\/cdd.2016.8","volume":"23","author":"Z Su","year":"2016","unstructured":"Su Z, Yang Z, Xie L, DeWitt JP, Chen Y. Cancer therapy in the necroptosis era. Cell Death Differ. 2016;23:748\u201356.","journal-title":"Cell Death Differ"},{"key":"8377_CR46","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-019-1029-8","volume":"18","author":"Y Gong","year":"2019","unstructured":"Gong Y, Fan Z, Luo G, Yang C, Huang Q, Fan K, et al. The role of necroptosis in cancer biology and therapy. Mol Cancer. 2019;18:100.","journal-title":"Mol Cancer"},{"key":"8377_CR47","doi-asserted-by":"publisher","first-page":"1757","DOI":"10.1038\/s41418-021-00785-0","volume":"28","author":"S Martens","year":"2021","unstructured":"Martens S, Bridelance J, Roelandt R, Vandenabeele P, Takahashi N. MLKL in cancer: more than a necroptosis regulator. Cell Death Differ. 2021;28:1757\u201372.","journal-title":"Cell Death Differ"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-08377-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-08377-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-08377-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T21:04:07Z","timestamp":1767042247000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-08377-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,22]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["8377"],"URL":"https:\/\/doi.org\/10.1038\/s41419-025-08377-3","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-7286420\/v1","asserted-by":"object"}]},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,22]]},"assertion":[{"value":"15 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 November 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 December 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 December 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All animal experiments were performed in accordance with the NIH Guide for the Care and Use of Laboratory Animals, with the approval of the Scientific Investigation Board of the School of Life Sciences, Fudan University (2020-JS-016).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"921"}}